EGFR and neoplasm: However, previous studies in human cell lines [30]–[32] and our present results show that overactivation of EGF signaling can promote apoptosis, raising the concern that drugs that antagonize EGFR signaling might have an anti-apoptotic effect and thus a potential tumor-promoting side-effect, depending on the cellular context.